Choline alfoscerate

DB04660InvestigationalSmall molecule

Choline alfoscerate is a natural choline that is used to manage declining cognitive function associated with neurodegenerative and vascular diseases. A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids.

Chemical structure of Choline alfoscerate
Formula / weight
C8H20NO6P · 257.223 g/mol (avg)
Also known as
alpha-Glycerophosphorylcholine · Choline alphoscerate · Choline glycerophosphate · Glycerol phosphorylcholine · Glycerophosphocholine

Resolves to

Compound
UNII60M22SGW66CAS28319-77-9ChEMBLCHEMBL1567463ChEBI16870PubChem657272KEGGD07349
Clinical / RWD
RxNorm4918ATCN07AX02
Structure
InChIKeySUHOQUVVVLNYQR-MRVPVSSYSA-NSMILES[H][C@@](O)(CO)COP([O-])(=O)OCC[N+](C)(C)C
Targets
P08912CHRM5P17900GM2A

What you can answer from here — as of September 12, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
13Marketed productsAcross 2 countries and 5 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Choline alfoscerate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In